Bart J. Van Den Bemt-Van Den Bergh
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Salivary flow measurements in a clinical setting: the Dutch consensus statement.
Journal: Clinical oral investigations
Published: December 08, 2025
Balancing overpayment from the home and hospital medication budgets in patients using their own medication during admission: the effect of different resupply strategies in the Netherlands.
Journal: European journal of hospital pharmacy : science and practice
Published: August 15, 2025
The frequency and impact of drug-related problems with postoperative medication reported by orthopaedic patients after discharge.
Journal: European journal of hospital pharmacy : science and practice
Published: August 16, 2024
Long-term clinical and radiological effectiveness and safety of ultralow doses of rituximab in rheumatoid arthritis: observational extension of the REDO trial.
Journal: RMD open
Published: August 30, 2023
Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial.
Journal: Annals of the rheumatic diseases
Published: September 25, 2022
The association between patient satisfaction with information and adherence to oral anticancer agents.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: February 07, 2022
Patients' perspectives on a drug safety monitoring system for immune-mediated inflammatory diseases based on patient-reported outcomes.
Journal: Expert opinion on drug safety
Published: August 05, 2021
A Serious Puzzle Game to Enhance Adherence to Antirheumatic Drugs in Patients With Rheumatoid Arthritis: Systematic Development Using Intervention Mapping.
Journal: JMIR serious games
Published: June 30, 2021
Therapeutic drug monitoring of adalimumab in RA: no predictive value of adalimumab serum levels and anti-adalimumab antibodies for prediction of response to the next bDMARD.
Journal: Annals of the rheumatic diseases
Published: January 14, 2020
Down-titration and discontinuation strategies of tumour necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.
Journal: The Cochrane database of systematic reviews
Published: May 25, 2019
Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: a discrete choice experiment.
Journal: Patient preference and adherence
Published: February 11, 2019
A discrete choice experiment on preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: the identification, refinement, and selection of attributes and levels.
Journal: Patient preference and adherence
Published: September 11, 2018
Last Updated: 09/26/2026